SURGICAL MESH SYSTEM
K053215 · Nuvasive, Inc. · FTL · Jul 17, 2006 · General, Plastic Surgery
Device Facts
| Record ID | K053215 |
| Device Name | SURGICAL MESH SYSTEM |
| Applicant | Nuvasive, Inc. |
| Product Code | FTL · General, Plastic Surgery |
| Decision Date | Jul 17, 2006 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 878.3300 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The Surgical Mesh System is intended to be implanted to reinforce soft tissue where weakness exists. The device is intended for one-time use.
Device Story
NuVasive Surgical Mesh System consists of specialized shapes of surgical mesh fabricated from commercially available polyester suture fibers. Device incorporates regions of reinforced holes to facilitate secure anchoring to tissue. Available in various shapes and sizes to accommodate individual patient pathology and anatomical conditions. Intended for implantation by surgeons to reinforce soft tissue weaknesses. Device is for one-time use only.
Clinical Evidence
No clinical data. Substantial equivalence supported by mechanical testing.
Technological Characteristics
Materials: Commercially available polyester suture fibers. Design: Specialized shapes with reinforced holes for anchoring. Energy source: None (passive implant). Sterilization: Not specified. Connectivity: None. Software: None.
Indications for Use
Indicated for reinforcement of soft tissue where weakness exists. For prescription use only.
Regulatory Classification
Identification
Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.
Related Devices
- K081377 — NUVASIVE SURGICAL MESH SYSTEM · Nuvasive, Inc. · Jan 15, 2009
- K020853 — NUVASIVE MESH · Nuvasive, Inc. · Jun 13, 2002
- K072370 — SURGICRAFT SURGICAL MESH SYSTEM · Surgicraft , Ltd. · Jul 24, 2008
- K043191 — REPOL ANGIMESH, ANGIMESH PRE, FOLDED MESH, REPOL PLUG BASIC, REPOL PLUG CAP, REPOL PLUG FLOWER AND WINGS MESH · Angiologica B. M. Srl · May 16, 2005
- K980431 — SURGISIS · Cook Biotech, Inc. · May 28, 1998
Submission Summary (Full Text)
{0}------------------------------------------------
# JUL 1 7 2006
Image /page/0/Picture/1 description: The image shows the text "NuVasive®, Incorporated". The text is in a serif font and is black. The registered trademark symbol is next to the word NuVasive.
510(k) Premarket Notification Surgical Mesh System <053215
#### 5. 510(K) SUMMARY
In accordance with the Safe Medical Devices Act (SMDA) of 1990 and Title of the Code of Federal Regulations Part 807 (21 CFR §807), and in particular §807.92, the following summary of safety and effectiveness information is provided:
### A. Submitted by
Laetitia Cousin Director of Regulatory Affairs and Quality Assurance NuVasive, Incorporated 4545 Towne Centre Court San Diego, CA 92121 Telephone: (858) 909-1868 Date Prepared: July 6, 2006.
- B. Device Name
Trade or Proprietary Name: Common or Usual Name: Classification Name:
NuVasive Surgical Mesh System Surgical Mesh Surgical Mesh (21 CFR Part 878.3300; Surgical Mesh, Class II, Product Code FTL.)
#### C. Predicate Devices
The subject device is substantially equivalent to similar previously cleared devices.
#### D. Device Description
The NuVasive Surgical Mesh System consists of a series of specialized shapes of surgical mesh made from commercially available polyester suture fibers. All sizes incorporate regions of reinforced holes to assist secure anchoring of the mesh to tissue. Thoodpoines are available in a variety of different shapes and sizes to suit the individual pathology and anatomical conditions of the patient.
#### E. Intended Use
The Surgical Mesh System is intended to be implanted to reinforce soft tissue where weakness exists. The device is intended for one-time use.
{1}------------------------------------------------
2/2
## F. Comparison to Predicate Devices
As was established in this submission, the subject device is substantially equivalent to other devices cleared by the agency for commercial distribution in the United States.
Engineering drawings, labeling, and mechanical testing have demonstrated that the subject device is substantially equivalent, if not identical, to its predicate devices in terms of design, materials of composition, indications for use, and such other characteristics as may be associated with the manufacture of any medical device.
## G. Summary of Non-Clinical Tests
Mechanical testing was presented.
## H. Summary of Clinical Tests
(Not Applicable).
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines representing its wings or feathers. The logo is surrounded by text that reads "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" in a circular arrangement. The text is in all capital letters and is positioned around the upper half of the circular logo.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
# JUL 1 7 2006
NuVasive. Inc. % Ms. Letitia Cousin Director, Regulatory Affairs and Quality Assurance 4545 Towne Centre Court San Diego, California 92121
Re: K053215
Trade/Device Name: NuVasive Surgical Mesh Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: FTL Dated: June 16, 2006 Received: June 19, 2006
Dear Ms. Cousin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
{3}------------------------------------------------
## Page 2 – Ms. Letitia Cousin
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Barbara Buchup
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# Indications for Use
510(k) Number (if known): K053215
Device Name: NuVasive Surgical Mesh
Indications For Use:
The Surgical Mesh System is intended to be implanted to reinforce soft tissue where weakness exists. The device is intended for one-time use.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Aubare Buchamp for mcan
(Division Sign-Off)
Page 1 of 1
Division of General, Restorative and Neurological Devices
510(k) Number k053215